Issued Patents All Time
Showing 26–40 of 40 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10370366 | Pyridazinone compounds and methods for the treatment of cystic fibrosis | Richard A. Nugent, Andrew Kolodziej, Karen Handley, Yevgen Barsukov | 2019-08-06 |
| 10280160 | Phthalazinone compounds and methods for the treatment of cystic fibrosis | — | 2019-05-07 |
| 10072017 | Compounds and methods for the treatment of cystic fibrosis | Michael P. Zawistoski, Asmita Deshpande | 2018-09-11 |
| 9944603 | Compounds and methods for the treatment of cystic fibrosis | Michael P. Zawistoski, Yevgen Barsukov, Richard A. Nugent | 2018-04-17 |
| 9926315 | Triazolopyridine compounds and methods for the treatment of cystic fibrosis | Richard A. Nugent, Paul Smith | 2018-03-27 |
| 9855249 | Isoxazole compounds and methods for the treatment of cystic fibrosis | Andrew Kolodziej | 2018-01-02 |
| 9790215 | Pyridazinone compounds and methods for the treatment of cystic fibrosis | Richard A. Nugent, Andrew Kolodziej, Karen Handley, Yevgen Barsukov | 2017-10-17 |
| 9783529 | Pyridazinone compounds and methods for the treatment of cystic fibrosis | Richard A. Nugent, Andrew Kolodziej, Karen Handley, Yevgen Barsukov | 2017-10-10 |
| 9771327 | Compounds and methods for the treatment of cystic fibrosis | Michael P. Zawistoski, Yevgen Barsukov, Richard A. Nugent | 2017-09-26 |
| 9682969 | Phthalazinone compounds and methods for the treatment of cystic fibrosis | — | 2017-06-20 |
| 9573948 | Triazolopyridine compounds and methods for the treatment of cystic fibrosis | Richard A. Nugent, Paul Smith | 2017-02-21 |
| 8937178 | Phthalazinone compounds and methods for the treatment of cystic fibrosis | — | 2015-01-20 |
| 6720330 | Somatostatin antagonists and agonists that act at the SST subtype 2 receptor | Bruce A. Hay, Anthony Ricketts | 2004-04-13 |
| 6696418 | Somatostatin antagonists and agonists that act at the SST subtype 2 receptor | Bruce A. Hay, Anthony Ricketts | 2004-02-24 |
| 6495589 | Somatostatin antagonists and agonists that act at the SST subtype 2 receptor | Bruce A. Hay, Anthony Ricketts | 2002-12-17 |